Form 5 - Annual statement of changes in beneficial ownership of securities:
SEC Accession No. 0001181431-06-006170
Filing Date
2006-01-27
Accepted
2006-01-27 17:46:50
Documents
1
Period of Report
2005-12-31

Document Format Files

Seq Description Document Type Size
1 FORM 5 -2005 rrd105259.html 5  
1 FORM 5 -2005 rrd105259.xml 5 8476
  Complete submission text file 0001181431-06-006170.txt   10341
Mailing Address 155 FEDERAL STREET BOSTON MA 02110
Business Address 155 FEDERAL STREET BOSTON MA 02110 6179332130
POINT THERAPEUTICS INC (Issuer) CIK: 0000919745 (see all company filings)

EIN.: 043216862 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address 338 N ST MEDFIELD MA 02052
Business Address
ROBLE DANIEL T (Reporting) CIK: 0001252297 (see all company filings)

Type: 5 | Act: 34 | File No.: 000-23776 | Film No.: 06559452